Results 11 to 20 of about 5,703,192 (247)

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy

Türk Kardiyoloji Derneği Arşivi, 2017
Summary– Septal reduction therapy (SRT) is the accepted therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). At this time, surgical septal myectomy is the gold standard method, but alcohol septal ablation is an acceptable ...
Tolga Aksu, Tümer Erdem Güler, Kıvanç Yalın, Şükriye Ebru Gölcük, Kazım Serhan Özcan   +4 more
doaj   +2 more sources

Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy

ESC Heart Failure, 2023
Aims Mechanical function of the left atrium (LA) and the left ventricle (LV) has been demonstrated to be a prognostic factor in patients with hypertrophic cardiomyopathy (HCM).
Kyung Eun Ha, Kang‐Un Choi, Hee‐Jung Lee, Seo‐Yeon Gwak, Kyu Kim, Iksung Cho, Geu‐Ru Hong, Jong‐Won Ha, Chi Young Shim   +8 more
doaj   +2 more sources

Alcohol Septal Ablation [PDF]

Journal of Biomedical & Clinical Research, 2015
Since 1994, alcohol septal ablation (ASA) has been used as a minimally invasive treatment of patients with hypertrophic obstructive cardiomyopathy, resistant to conservative medical therapy. This catheter-based intervention consists of injecting absolute
Sotir Marchev, Boyko Kuzmanov
doaj   +4 more sources

Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Ramzi Ibrahim, Winston Wang, Hoang Nhat Pham, Mahmoud Abdelnabi, Steven J. Lester, Susan Wilansky, Hartzell V. Schaff, Jeffrey B. Geske, Reza Arsanjani, Chadi Ayoub   +9 more
doaj   +2 more sources

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?

ESC Heart Failure, 2023
Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority ...
Alexandru Achim, Adela Mihaela Serban, Stefan Dan Cezar Mot, Gregor Leibundgut, Madalin Marc, Ulrich Sigwart   +5 more
doaj   +1 more source

Cardiac Magnetic Resonance Identifies Responders to Cardiac Resynchronization Therapy with an Assessment of Septal Scar and Left Ventricular Dyssynchrony [PDF]

, 2023
International audienceBackground: The response to cardiac resynchronization therapy (CRT) depends on septal viability and correction of abnormal septal motion.
Penicka, Martin, Mathieu Lederlin, Einar Hopp, Camilla Kjellstad Larsen, Jürgen Duchenne, Jan Bogaert, Cecilia Linde, Elena Galli, Smiseth, Otto, A, Aalen, John Moene, Erwan Donal, Erik Kongsgaard, Linde, Cecilia, Galli, Elena, Kongsgaard, Erik, Larsen, Camilla Kjellstad, John Moene Aalen, Hopp, Einar, Otto A. Smiseth, Martin Penicka, Donal, Erwan, Voigt, Jens-Uwe, Bogaert, Jan, Lederlin, Mathieu, Jens-Uwe Voigt, Duchenne, Jürgen, Smiseth, OA, Aalen, JM, Kongsgaard, E, Linde, C,, Bogaert, J, Galli, E, Duchenne, J, Smiseth, Otto A., Larsen, CK, Penicka, M, Lederlin, M   +36 more
core   +1 more source

Long-term outcomes of surgery for obstructive hypertrophic cardiomyopathy in a pediatric cohortCentral MessagePerspective

JTCVS Open, 2023
Background: Septal reduction therapy via septal myectomy or a modified Konno procedure is the mainstay of therapy for drug-refractory obstructive hypertrophic cardiomyopathy (HCM), although outcomes data on septal myectomy in pediatric patients are ...
Stephanie N. Nguyen, MD, Megan M. Chung, BA, Alice V. Vinogradsky, BA, Marc E. Richmond, MD, MS, Warren A. Zuckerman, MD, Andrew B. Goldstone, MD, PhD, Emile A. Bacha, MD   +6 more
doaj   +1 more source

Endocardial Radiofrequency Ablation vs. Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis

Frontiers in Surgery, 2022
BackgroundSeptal myectomy (SM) has been the gold standard therapy for most patients with hypertrophic obstructive cardiomyopathy (HOCM). Endocardial radiofrequency ablation of septal hypertrophy (ERASH) is a novel treatment for septal reduction. We aimed
Tao Jiang, Bingyu Huang, Shengqi Huo, Lulu Monica Mageta, Junyi Guo, Jiagao Lv, Li Lin   +6 more
doaj   +1 more source

Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy?

Türk Kardiyoloji Derneği Arşivi, 2018
Hypertrophic obstructive cardiomyopathy is an inheritable cardiac disease that typically manifests with an increased left ventricular outflow tract gradient.
Elnur Alizade, Sabahattin Gündüz, Ahmet Güner, Khagani Isgandarov, Selçuk Pala   +4 more
doaj   +1 more source

Application of a Model of Family-Centered Harm Reduction in Community-Based Programming [PDF]

, 2023
Coupling high substance use disorder rates with the effects of the COVID-19 pandemic, our nation faces a growing mental health crisis and a shortage of adequately trained mental and behavioral health providers.
Johnna Belkiewitz, Victoria G. Wilburn, Kate Schrader, Belkiewitz, Johnna, Wilburn, Victoria G., Larson, Sydney, Sydney Larson, Schrader, Kate   +7 more
core   +1 more source